Aurex (Citalopram)

Quick links

Choose a section

Quick links to important sections

Advertisements

Aurex (Citalopram)

Advertisements
Advertisements

Treatment option: Depression, Neurosis

Advertisements

Overview of Aurex (Citalopram)

Quick Facts

Property Description
Active ingredient Citalopram (Citalopram hydrobromide)
Form Oral tablet, Oral solution
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Origin Synthetic compound

What Type of Medicine is Aurex (Citalopram)?

Aurex is a brand name for a medication whose core active component is Citalopram, a psychotropic agent classified as an antidepressant and specifically a Selective Serotonin Reuptake Inhibitor (SSRI). Citalopram is a synthetic compound designed to modulate signaling in the central nervous system. Its use in supporting emotional well-being is a recognized application of its pharmacological properties. The substance is administered as a racemic mixture, chemically containing equal parts of the R- and S-enantiomers.


Composition and Available Forms of Citalopram

The medication is a single-ingredient product, containing only Citalopram (often utilized as the hydrobromide salt) as its active substance. It is designed for oral administration and is primarily available in two key dosage forms: the conventional oral tablet and an oral solution. The availability of the oral solution form provides a differentiating factor for the medication, allowing for flexible administration.


General Purpose of Citalopram Therapy

The general therapeutic purpose of Citalopram is to modulate and stabilize the brain’s serotonin system, a critical pathway for emotional balance. Its function involves inhibiting the neuronal reuptake of serotonin, thereby increasing its functional availability in the central nervous system. This pharmacological action is intended to help the brain maintain stability in mood and emotional reactivity, which is the foundational therapeutic benefit of the medication.

Advertisements

What side effects are possible with Aurex (Citalopram)?

Possible Side Effects and Safety Information

The safety profile of Citalopram, the active ingredient in Aurex, is formally structured by government regulatory agencies, which classify adverse reactions by frequency and physiological system. This classification helps define the risk profile based on clinical trial data.


Frequency-Classified Adverse Reactions

Adverse effects are categorized based on their incidence as documented in official prescribing information:

  • Very Common (Affecting ge 1 in 10): Reactions include nausea, dry mouth (xerostomia), somnolence, insomnia, and headache.
  • Common (Affecting ge 1 in 100 to < 1 in 10): Reported effects include increased sweating (hyperhidrosis), diarrhea, constipation, tremor, and various forms of sexual dysfunction.

These effects are formally grouped into System-Organ Classes, such as Gastrointestinal Disorders, Nervous System Disorders, and Psychiatric Disorders.


Serious Adverse Reactions and Safety Constraints

The official safety information highlights specific, potentially serious reactions and limitations:

  • Cardiac Risk: The medicine has a documented risk of QT-prolongation, a potentially serious effect on heart rhythm that is formally stated to be dose-dependent. Use is restricted in patients with congenital long QT syndrome.
  • Neurological Risks: Official labeling carries warnings regarding Serotonin Syndrome, a serious condition resulting from excessive serotonergic activity, and an increased risk of suicidal thoughts and behaviors in young adults during the initial months of therapy or following dose adjustments.
  • Vulnerable Populations: Specific safety considerations are mandated for certain groups. Older adults often require a lower maximum dose due to a higher risk of QT-prolongation and Hyponatremia (low blood sodium). Similarly, a lower maximum dose is often specified for individuals with hepatic impairment.
Advertisements

Overdose and Emergency Response

The official regulatory documents define the overdose profile of Citalopram (Aurex) based on documented clinical manifestations and the potential for severe, life-threatening outcomes. Overdose may initially present with common Central Nervous System (CNS) signs such as somnolence, dizziness, confusion, and tremor. Gastrointestinal effects including nausea and vomiting are commonly reported.

The most critical documented risks involve severe Cardiovascular Toxicity, characterized by dose-dependent QTc prolongation and the risk of serious ventricular arrhythmia, including Torsade de Pointes. Severe neurological manifestations such as convulsions (seizures) and coma are also officially documented outcomes. The official profile notes that features consistent with Serotonin Syndrome may occur.

Immediate medical attention is required upon any suspicion of overdose. Regulatory guidance explicitly mandates contacting emergency services immediately if the affected individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Furthermore, individuals experiencing an irregular heartbeat, fainting, or shortness of breath must seek immediate care.

No specific antidote is known for Citalopram overdose. Treatment described in regulatory information is symptomatic and supportive, requiring careful monitoring of vital signs and continuous ECG monitoring for cardiac risk. The regulatory labeling highlights special consideration for older patients and those with hepatic impairment due to their heightened risk of cardiac toxicity.

Advertisements

Therapeutic Uses of Aurex (Citalopram)

What Aurex (Citalopram) Treats: Main Uses and Benefits

The therapeutic use of Aurex (Citalopram) is centered on providing supportive relief for symptom-driven clinical presentations across key mood and anxiety domains, helping patients manage episodes of heightened emotional distress. Citalopram is commonly used to help with symptoms related to conditions involving episodic or fluctuating manifestations such as depression in adults and is considered relevant for older adults. It is also commonly used in situations involving certain distressing symptoms such as those associated with panic disorder.

Citalopram is primarily applied across conditions presenting with debilitating Major Depressive Disorder (MDD) and is relevant for easing the intensity of acute episodes associated with Panic Disorder. This supportive benefit is relevant when supportive symptom management is appropriate, and it provides support that helps ease the overall symptom burden. The medication may be part of symptomatic management for conditions involving episodic or fluctuating manifestations.

Managing Core Symptoms and Benefits

Citalopram is primarily relevant for conditions characterized by persistent low mood, feelings of emptiness, and the debilitating loss of interest or pleasure in daily activities. It is applied in clinical settings marked by significant affective distress to help ease the overall symptom burden of depressive manifestations and supports general well-being during symptomatic phases. Furthermore, for anxiety-related distress, it is commonly used across conditions that present with disruptive manifestations of fear, offering symptomatic relief which may assist with maintaining functional stability during phases of increased discomfort.


Quick Fact: Relief for Mood and Anxiety
Primary Focus Major Depressive Disorder (MDD), Panic Disorder.
Symptom Domains Persistent low mood, loss of interest (anhedonia), and disruptive fear/anxiety attacks.
Key Benefit Contributes to easing the overall symptom load, supporting functional stability.

Regulatory References

  1. NIH StatPearls overview
Advertisements

Eligibility and Restrictions for Use

Citalopram is strictly limited to the adult population (18 years and older) for approved use; the medicine is not approved for use in pediatric patients.

Use is contraindicated in patients with a known hypersensitivity to citalopram or its ingredients. It must not be used in patients concurrently taking Monoamine Oxidase Inhibitors (MAOIs) (including linezolid or intravenous methylene blue) or in those taking Pimozide. Use is also prohibited in patients with congenital long QT syndrome or those taking other medications known to prolong the QT interval.

Specific populations require limited or conditional use based on regulatory label restrictions:

Population Group Regulatory Restriction Status
Older Adults (60+), Hepatic Impairment, CYP2C19 Poor Metabolizers Max dose restriction (20 mg per day)
Severe Renal Impairment Use with caution (limited data available)
Pregnancy/Lactation Conditional use (benefit must outweigh potential risk)

Caution is further required for patients with a history of mania, hypomania, or seizures, or those with uncorrected hypokalemia or hypomagnesemia.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Aurex (Citalopram) strictly identifies substance classes and individual medicinal products that require restriction or total prohibition of co-administration, based on documented pharmacokinetic and pharmacodynamic outcomes.


Contraindicated Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally prohibited due to the documented risk of Serotonin Syndrome. This prohibition includes agents like Linezolid and Intravenous Methylene Blue. Citalopram is also contraindicated with Pimozide and other medicinal products known to prolong the QT interval, based on the potential for an additive effect on cardiac repolarization. A mandatory washout period of at least 14 days is required when switching from an irreversible MAOI to Citalopram, and at least 7 days when switching in the opposite direction.


Pharmacokinetic and Pharmacodynamic Interactions

A pharmacokinetic interaction occurs with inhibitors of the CYP2C19 enzyme, such as Cimetidine and Omeprazole. This inhibition officially leads to increased Citalopram plasma concentrations. This constraint dictates a maximum dose restriction in populations like those with hepatic impairment and individuals identified as CYP2C19 poor metabolizers. The risk of bleeding abnormalities is documented as increased when co-administered with drugs that interfere with hemostasis, including NSAIDs and oral anticoagulants. Co-use of the herbal product St. John's Wort is to be avoided due to the potential for enhanced serotonergic effects.

Advertisements

Mechanism of Action

Citalopram is a Selective Serotonin Reuptake Inhibitor (SSRI) that exerts its primary action by engaging the Serotonin Transporter (SERT) protein in the central nervous system. This interaction involves non-competitive binding to SERT, which results in the inhibition of serotonin (5-HT) reuptake into the presynaptic neuron. Consequently, the concentration of free 5-HT increases within the synaptic cleft, leading to enhanced activation of postsynaptic 5-HT receptors.

This immediate signaling modulation initiates a cascade of downstream effects. Over time, chronic exposure induces neuroadaptive changes, including alterations in the sensitivity and expression density of various 5-HT receptors. Furthermore, Citalopram influences long-term cellular processes such as neurogenesis in specific limbic and cortical regions, promoting sustained modulation of signal transduction within targeted neural circuits. This sequence of molecular actions defines the drug's effect profile entirely through biochemical and physiological adjustment.

Advertisements

Dosage and Administration Information

How to Use Aurex (Citalopram): Administration Guidelines

Citalopram is intended for oral administration and is typically taken once daily. Standard instructions allow for the medication to be administered with or without food, at any time of day. It is available as film-coated tablets, often scored to facilitate division, and as an oral solution for patients requiring liquid dosing.


Standard Dosing and Adjustment

Treatment initiation for Major Depressive Disorder (MDD) often begins with a dose of 20 mg once daily for general adult patients. The dose may be adjusted upward to a maximum of 40 mg once daily, but dose increases must only occur after a minimum treatment interval of one week at the current level. If a dose is missed, patients should skip the missed dose and continue with the next scheduled dose; double dosing is not recommended.


Population-Specific Restrictions and Course Length

Specific patient populations have a lower maximum daily dose of 20 mg due to pharmacokinetic considerations. This restriction applies to older adults (typically age 65 and above) and patients diagnosed with hepatic impairment (reduced liver function). Regarding duration, guidance for MDD suggests that treatment should generally be continued for at least six months after symptom resolution to maintain stability. When treatment is concluded, the dose must be gradually reduced over a period of at least one to two weeks before discontinuation to minimize procedural constraints.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

This section summarizes research that has explored the Citalopram compound and the outcomes reported in clinical trials for its use in treating Major Depressive Disorder (MDD).


Compound Characteristics and Primary Outcomes

Compound Characteristics: Research has examined the drug's relationship with serotonergic activity.

Studies investigated Citalopram, which functions as a selective serotonin reuptake inhibitor (SSRI). Researchers examined whether the administration of the drug was associated with changes in symptoms of MDD, typically over an 8-week period. Large-scale Randomized Controlled Trials (RCTs) have been conducted to investigate outcomes compared to a placebo.

  • Symptom Reduction: Trials evaluated changes in symptom severity using standardized rating scales, such as the Hamilton Depression Rating Scale (HAM-D). Findings consistently suggested greater change scores in groups receiving Citalopram compared to placebo.
  • Long-Term Follow-up: Open-label extension studies have continued to monitor participants over several years, with researchers tracking safety events and long-term changes in symptoms following initial treatment.

Comparative Findings and Safety Assessment

Comparative Effectiveness: A meta-analysis comparing Citalopram to the active S-enantiomer, Escitalopram, has investigated potential differences in efficacy. While both compounds are effective, some research suggests Escitalopram may show statistically greater efficacy and tolerability compared to the racemic Citalopram.

Safety Assessment in Trials: Clinical trials included assessments of potential adverse events in adults.

  • Adverse Events: The most commonly reported events included nausea, dry mouth, somnolence (drowsiness), and increased sweating. These events are generally reported as mild to moderate in severity.
  • Cardiac Monitoring: Studies have shown that Citalopram can cause dose-dependent QT interval prolongation, an electrical change in the heart, which necessitates careful cardiac monitoring, especially in those with pre-existing heart conditions. Updated regulatory guidance recommends a maximum dose of 40 mg per day for most adults.

Key Studies & References

  1. NICE Guideline NG222: Depression in adults: treatment and management.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Aurex (Citalopram) (FAQ)

Q: Is Aurex (Citalopram) considered an anti-anxiety drug or an antidepressant?

A: Official product information classifies Citalopram as an antidepressant and indicates it is approved by the FDA primarily to treat Major Depressive Disorder (MDD). However, regulatory documents in certain countries also approve its use for conditions like Panic Disorder.

Q: Is it normal to feel worse before feeling better when starting Aurex?

A: Official regulatory documents caution that a worsening of depression and the emergence of suicidal thoughts and behaviors may occur during the first few months of treatment or following dose changes. Regulatory documents state that this emergence of symptoms is monitored in clinical settings, particularly in young adults.

Q: Does Aurex (Citalopram) cause weight gain in most people?

A: Clinical trial data summarized in the official label reports that a small percentage of patients experienced a change in weight. This included reports of both weight loss and weight gain over the course of the short-term studies.

Q: Should I avoid drinking alcohol completely while taking Aurex (Citalopram)?

A: According to official regulatory guidance, combining Citalopram tablets with alcohol is generally not recommended. This is a common precaution associated with psychotropic medications.

Q: How long does Citalopram stay in your system after you stop taking it?

A: Regulatory pharmacokinetic information states that the drug's mean terminal elimination half-life is approximately 35 hours. The half-life is the time it takes for the concentration of the drug in the body to be reduced by half.

Q: Why do some people experience 'brain zaps' when they stop Citalopram?

A: Stopping Citalopram suddenly can cause what is known as discontinuation syndrome. Official documents note that symptoms can include dizziness and a range of electric shock-like sensations (sometimes described as 'brain zaps'), along with confusion and anxiety.

Q: Is Aurex (Citalopram) used to treat conditions other than depression and anxiety?

A: The FDA-approved use for Citalopram is Major Depressive Disorder. Some regulatory bodies, however, have also approved Citalopram for conditions like Panic Disorder, which is a type of anxiety disorder.

Q: What percentage of people experience significant relief from depression with Citalopram?

A: Clinical trials show that Citalopram results in statistically greater improvement scores in symptoms compared to a placebo. Detailed efficacy data, including specific responder percentages, is available in the full clinical trial summaries.

Q: Are there different dosages of Aurex (Citalopram), and what are they used for?

A: The tablets are manufactured in several dosage strengths, such as 10 mg, 20 mg, and 40 mg. Official guidance restricts the maximum recommended daily dose for most adults to a specific limit.

Q: Can Aurex (Citalopram) affect a person's ability to concentrate?

A: Official adverse effects listed in the product label include dizziness and somnolence (drowsiness). These effects on the central nervous system may impact a person’s attention and ability to concentrate.

Q: Is it common to have vivid dreams or night sweats when taking Aurex?

A: Official prescribing information lists increased sweating (hyperhidrosis) as a common side effect and insomnia (difficulty sleeping) as a very common side effect. Vivid dreams are not explicitly listed in the frequency-classified adverse events.

Q: Are there any long-term effects of taking Aurex (Citalopram) for several years?

A: Regulatory documents list safety concerns that are monitored regardless of treatment duration, such as suicidal thoughts, QT prolongation (a heart rhythm concern), and the risk of Serotonin Syndrome. Long-term open-label studies track these safety events.

Q: How can I tell the difference between normal side effects and something more serious while on Citalopram?

A: Regulatory warnings highlight specific, potentially serious effects like signs of Serotonin Syndrome (including agitation, fever, hallucinations) and symptoms of QT prolongation (such as irregular heartbeat). These events are classified as serious and require prompt medical evaluation.

Q: Can Aurex (Citalopram) cause changes in appetite?

A: Clinical trial data reported in official sources lists anorexia (loss of appetite) as a possible side effect. Changes in appetite are often linked to the general weight changes reported in some patients.

Q: Are there any known genetic factors that affect how someone responds to Citalopram?

A: Yes, official prescribing information mandates a maximum dose restriction for patients who are known to be CYP2C19 poor metabolizers. This restriction is in place because this genetic difference can affect how the drug is processed by the body.

Q: What should someone do if they feel dizzy after starting Aurex?

A: Because Citalopram can cause drowsiness and dizziness, regulatory documents caution that effects like this may impair the ability to perform hazardous tasks, such as driving or operating machinery.

Q: How long does it usually take to feel the effects of Aurex (Citalopram)?

A: Official guidance does not provide an exact timeframe for symptom improvement. It only details that dose adjustments should not occur until after a minimum of one week of treatment and that the total course for MDD should generally last at least six months.

Q: What is the difference between Aurex (Citalopram) and Lexapro (Escitalopram)?

A: Official research summaries note that Citalopram is a racemic mixture, meaning it contains two chemical forms, while Escitalopram (Lexapro) contains only the active S-enantiomer. Both are effective, but studies have investigated potential differences in efficacy and tolerability between the two compounds.

Q: Why is it important to check my heart health before starting Aurex?

A: The official safety information highlights a documented, dose-dependent risk of QT-prolongation, which is a potentially serious effect on the heart’s electrical activity. This risk necessitates caution, especially for individuals with pre-existing heart conditions.

Q: Can taking Aurex (Citalopram) affect my sex drive?

A: Official side effect profiles list sexual dysfunction as a common adverse reaction reported in clinical trials. This category can include changes in a person's sex drive or libido.

Q: What happens if I miss a dose of Aurex (Citalopram)?

A: Official labeling contains specific guidance regarding a missed dose, stating that patients should generally continue with their next scheduled dose without attempting to double-dose.

Q: Can I take Aurex (Citalopram) if I am trying to become pregnant?

A: Regulatory documents state that the use of Citalopram during pregnancy is conditional. The official guidance dictates that the potential benefit must be carefully weighed against any potential risks to the fetus.

Q: Is it important to take Aurex (Citalopram) at the exact same time every day?

A: The official labeled instructions allow for the medication to be administered at any time of day and can be taken with or without food. Consistency, however, is generally important for maintaining stable drug blood levels.

Q: Is it true that you have to taper off Aurex (Citalopram) instead of stopping suddenly?

A: Official prescribing information states that when treatment is to be concluded, the dose must be gradually reduced over a period of at least one to two weeks before discontinuation. This is done to minimize potential discontinuation symptoms.

Q: What are some signs that Aurex might not be working for someone?

A: Clinical trial evidence primarily focuses on the drug's success in achieving symptom reduction using standardized rating scales. A lack of observed improvement in core symptoms of Major Depressive Disorder following an adequate period of treatment suggests the medication may not be working as intended.

Advertisements

How should Aurex (Citalopram) be stored and disposed of?

How to Store and Dispose of Aurex (Citalopram)

Citalopram (Aurex) must be stored under specific environmental and container conditions as defined by regulatory labeling.


Official Storage Requirements

Requirement Condition
Temperature Store at controlled room temperature, between 20^circ to 25 C (68^circ to 77 F).
Container The medication bottle must be kept closed tightly to protect the product.
Child Safety Must be kept out of the reach of children to prevent accidental ingestion.

Storage outside of the permitted temperature range, which extends up to 30 C (86 F), is prohibited for maintaining stability.


Disposal Instructions

For disposal of unused or expired Citalopram, the recommended method is the use of a drug take-back program. Citalopram is not on the list of medications that should be flushed down the toilet. If a take-back program is unavailable, official guidance requires mixing the medicine with an unappealing substance, placing the mixture in a sealed bag, and discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aurex (Citalopram) found in:

A-Z Index: